missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

Endothelial Lipase Polyclonal Antibody, Invitrogen™

Endothelial Lipase Antibody, PA1-16793, from Invitrogen™. Species Reactivity: Human; Applications: ICC, IF, IHC (Frozen), WB.

Manufacturer:  Pierce Biotechnology Inc PA116793

Catalog No. APPA6793


 

Specifications

Description

Endothelial Lipase Antibody, PA1-16793, from Invitrogen. Species Reactivity: Human; Applications: Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Frozen), Western Blot.

Endothelial lipase (EL) is a novel member of the lipoprotein lipase gene family. It is synthesized by endothelial cells and functions at the site of synthesis. EL most likely plays a physiological role in modulating lipoprotein metabolism. Overexpressed EL has been shown to reduce HDL cholesterol levels, whereas an EL deficiency appears to be effective in elevating HDL cholesterol levels in animals.
Host Species: Rabbit
Cross Reactivity: Human
Isotype: IgG
Immunogen: A C-terminal synthetic peptide made to the human endothelial lipase protein sequence.
Formulation: 100μL purified antibody (1mg/mL) in tris citrate and 0.1% sodium azide; pH 7-8
Synonyms: EDL, EL, PRO719
Uniprot Accession: Q9Y5X9
Entrez GeneID: 9388
Gene Symbol: LIPG
This antibody is predicted to react with monkey based on 100% sequence homology. This antibody does not react with mouse.
Description & Specifications

Specifications

Endothelial Lipase
Unlabeled
Q9Y5X9
EDL, EL, PRO719
Rabbit
IgG
Store at 4° C
Polyclonal
Human
Immunocytochemistry,Immunofluorescence,Immunohistochemistry (Frozen),Western Blot
100μL purified antibody (1mg/mL) in tris citrate and 0.1% sodium azide; pH 7-8
Purified
LIPG
A C-terminal synthetic peptide made to the human endothelial lipase protein sequence.
100μL
Primary
9388
Promotions

Promotions

  • Purchase any three Invitrogen™ Antibodies and receive a fourth antibody at no additional cost. This is an NLSU exclusive offer. You must apply and qualify for the program to be eligible.

    06/30/18